<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34716673</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2162-3279</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>12</Issue><PubDate><Year>2021</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Brain and behavior</Title><ISOAbbreviation>Brain Behav</ISOAbbreviation></Journal><ArticleTitle>Prevalence of amyotrophic lateral sclerosis in Latium region, Italy.</ArticleTitle><Pagination><StartPage>e2378</StartPage><MedlinePgn>e2378</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2378</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/brb3.2378</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Prevalence estimate of amyotrophic lateral sclerosis (ALS) ranged between 1.1/100,000 and 11.2/100,000 inhabitants with different design of the study (prospective or retrospective) and sample size. The aim of this study is to conduct for the first time an estimate of the ALS prevalence in the Latium region.</AbstractText><AbstractText Label="MATERIALS AND METHODS">The study was performed in Latium, a region located in the center of Italy, with a population, as of January 1, 2016, of 5888.472 inhabitants. In this region, a network of 15 clinical centers (of which 4 referral ALS centers are located in Rome) and 10 local health authorities involved in the diagnosis and treatment of ALS patients has been identified. Each patient was classified according to the El Escorial revised criteria.</AbstractText><AbstractText Label="RESULTS">The prevalence study in 2016 identified 353 ALS cases (200 males). By considering population aged &gt;=20 years, the total crude prevalence rate resulted 7.33 (CI95% 6.59-8.14) &#xd7; 100,000 and 8.75 and 6.05 in males and females, respectively. Age-specific prevalence rates did not differ among males and females in the population aged less than 49 years. The difference emerged in population aged&#xa0;&gt;&#xa0;50 years. This type of diagnosis was recorded for 343 patients (11 missing). 68% of these patients have a definite diagnosis, 14% likely, 11% possible, and 12% defined as suspect.</AbstractText><AbstractText Label="CONCLUSIONS">The estimate of prevalence rates observed in this study is probably in line with the values reported in the literature for prospective prevalence studies.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. Brain and Behavior published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Puopolo</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bacigalupo</LastName><ForeName>Ilaria</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piscopo</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacorte</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-8530-9207</Identifier><AffiliationInfo><Affiliation>National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Pucchio</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santarelli</LastName><ForeName>Marialaura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Presidio Ospedaliero San Filippo Neri - ASL RM1, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inghilleri</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-5365-3417</Identifier><AffiliationInfo><Affiliation>Umberto I, Policlinico Universitario, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Petrucci</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7950-4970</Identifier><AffiliationInfo><Affiliation>S. Camillo Forlanini, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabatelli</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Latium Registry Group</CollectiveName></Author><Author ValidYN="Y"><LastName>Vanacore</LastName><ForeName>Nicola</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2817-3758</Identifier><AffiliationInfo><Affiliation>National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>10</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav</MedlineTA><NlmUniqueID>101570837</NlmUniqueID></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">epidemiology studies</Keyword><Keyword MajorTopicYN="N">neurodegenerative</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>31</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34716673</ArticleId><ArticleId IdType="pmc">PMC8671775</ArticleId><ArticleId IdType="doi">10.1002/brb3.2378</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Al&#x2010;Chalabi, A. , &amp; Hardiman, O. (2013). The epidemiology of ALS: A conspiracy of genes, environment, and time. Nature Reviews Neurology, 9(11), 617&#x2013;628. 10.1038/nrneurol.2013.203</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId><ArticleId IdType="pubmed">24126629</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur, K. C. , Calvo, A. , Price, T. R. , Geiger, J. T. , Chi&#xf2;, A. , &amp; Traynor, B. J . (2016). Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nature Communications, 7, 12408. 10.1038/ncomms12408</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12408</ArticleId><ArticleId IdType="pmc">PMC4987527</ArticleId><ArticleId IdType="pubmed">27510634</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi, E. , Millul, A. , Micheli, A. , Vitelli, E. , Logroscino, G. , &amp; SLALOM Group . (2007). Incidence of ALS in Lombardy, Italy. Neurology, 68(2), 141&#x2013;145. 10.1212/01.wnl.0000250339.14392.bb</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000250339.14392.bb</ArticleId><ArticleId IdType="pubmed">17210896</ArticleId></ArticleIdList></Reference><Reference><Citation>Binazzi, A. , Belli, S. , Uccelli, R. , Desiato, M. T. , Talamanca, I. F. , Antonini, G. , Corsi, F. M. , Scoppetta, C. , Inghilleri, M. , Pontieri, F. E. , &amp; Vanacore, N . (2009). ALS Rome Group. An exploratory case&#x2010;control study on spinal and bulbar forms of amyotrophic lateral sclerosis in the province of Rome. Amyotrophic Lateral Sclerosis, 10(5&#x2013;6), 361&#x2013;369. 10.3109/17482960802382313</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802382313</ArticleId><ArticleId IdType="pubmed">19922125</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks, B. R. , Miller, R. G. , Swash, M. , Munsat, T. L. , &amp; World Federation of Neurology Research Group on Motor Neuron Diseases . (2000). El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1(5), 293&#x2013;299. 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2;, A. , Cucatto, A. , Calvo, A. , Terreni, A. A. , Magnani, C. , &amp; Schiffer, D . (1999). Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy. Journal of Neurology, 246(3), 175&#x2013;180. 10.1007/s004150050330</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150050330</ArticleId><ArticleId IdType="pubmed">10323314</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2;, A. , Logroscino, G. , Hardiman, O. , Swingler, R. , Mitchell, D. , Beghi, E. , Traynor, B. G. , &amp; Eurals Consortium . (2009). Prognostic factors in ALS: A critical review. Amyotrophic Lateral Sclerosis, 10(5&#x2013;6), 310&#x2013;323. 10.3109/17482960802566824</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802566824</ArticleId><ArticleId IdType="pmc">PMC3515205</ArticleId><ArticleId IdType="pubmed">19922118</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2;, A. , Logroscino, G. , Traynor, B. J. , Collins, J. , Simeone, J. C. , Goldstein, L. A. , &amp; White, L. A . (2013). Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature. Neuroepidemiology, 41(2), 118&#x2013;130. 10.1159/000351153</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2;, A. , Mora, G. , Calvo, A. , Mazzini, L. , Bottacchi, E. , &amp; Mutani, R . (2009). PARALS. Epidemiology of ALS in Italy: A 10&#x2010;year prospective population&#x2010;based study. Neurology, 72(8), 725&#x2013;731. 10.1212/01.wnl.0000343008.26874.d1</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000343008.26874.d1</ArticleId><ArticleId IdType="pubmed">19237701</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2;, A. , Mora, G. , Moglia, C. , Manera, U. , Canosa, A. , Cammarosano, S. , Ilardi, A. , Bertuzzo, D. , Bersano, E. , Cugnasco, P. , Grassano, M. , Pisano, F. , Mazzini, L. , Calvo, A. , &amp; Piemonte and Valle d'Aosta Register for ALS (PARALS) . (2017). Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d'Aosta register. JAMA Neurology, 74(9), 1097&#x2013;1104. 10.1001/jamaneurol.2017.1387</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.1387</ArticleId><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgoulopoulou, E. , Vinceti, M. , Bonvicini, F. , Sola, P. , Goldoni, C. A. , De Girolamo, G. , Ferraro, D. , Nichelli, P. , &amp; Mandrioli, J . (2011). Changing incidence and subtypes of ALS in Modena, Italy: A 10&#x2010;years prospective study. Amyotrophic Lateral Sclerosis, 12(6), 451&#x2013;457. 10.3109/17482968.2011.593037</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.593037</ArticleId><ArticleId IdType="pubmed">21732732</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino, G. , &amp; Piccininni, M . (2019). Amyotrophic lateral sclerosis descriptive epidemiology: The origin of geographic difference. Neuroepidemiology, 52(1&#x2013;2), 93&#x2013;103. 10.1159/000493386</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493386</ArticleId><ArticleId IdType="pubmed">30602169</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino, G. , Traynor, B. J. , Hardiman, O. , Chio, A. , Couratier, P. , Mitchell, J. D. , Swingler, R. J. , &amp; Beghi, E . (2008). EURALS. Descriptive epidemiology of amyotrophic lateral sclerosis: New evidence and unsolved issues. Journal of Neurology, Neurosurgery, and Psychiatry, 79(1), 6&#x2013;11. 10.1136/jnnp.2006.104828</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.104828</ArticleId><ArticleId IdType="pubmed">18079297</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin, B. , Boum&#xe9;diene, F. , Logroscino, G. , Couratier, P. , Babron, M. &#x2010; C. , Leutenegger, A. L. , Copetti, M. , Preux, P. &#x2010; M. , &amp; Beghi, E. (2017). Variation in worldwide incidence of amyotrophic lateral sclerosis: A meta&#x2010;analysis. International Journal of Epidemiology, 46(1), 57&#x2013;74. 10.1093/ije/dyw061</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyw061</ArticleId><ArticleId IdType="pmc">PMC5407171</ArticleId><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin, B. , Fontana, A. , Arcuti, S. , Copetti, M. , Boum&#xe9;diene, F. , Couratier, P. , Beghi, E. , Preux, P. M. , &amp; Logroscino, G . (2018). Age&#x2010;specific ALS incidence: A dose&#x2010;response meta&#x2010;analysis. European Journal of Epidemiology, 33(7), 621&#x2013;634. 10.1007/s10654-018-0392-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-018-0392-x</ArticleId><ArticleId IdType="pubmed">29687175</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta, P. , Kaye, W. , Raymond, J. , Punjani, R. , Larson, T. , Cohen, J. , Muravov, O. , &amp; Horton, K . (2018). Prevalence of amyotrophic lateral sclerosis &#x2013; United States, 2015. MMWR Morbidity and Mortality Weekly Report, 67(46), 1285&#x2013;1289. 10.15585/mmwr.mm6746a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6746a1</ArticleId><ArticleId IdType="pmc">PMC6289079</ArticleId><ArticleId IdType="pubmed">30462626</ArticleId></ArticleIdList></Reference><Reference><Citation>Pliner, H. A. , Mann, D. M. , &amp; Traynor, B. J . (2014). Searching for Grendel: Origin and global spread of the C9ORF72 repeat expansion. Acta Neuropathologica, 127(3), 391&#x2013;396. 10.1007/s00401-014-1250-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1250-x</ArticleId><ArticleId IdType="pmc">PMC4545603</ArticleId><ArticleId IdType="pubmed">24496499</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugliatti, M. , Parish, L. D. , Cossu, P. , Leoni, S. , Ticca, A. , Saddi, M. V. , Ortu, E. , Traccis, S. , Borghero, G. , Puddu, R. , Chi&#xf2;, A. , &amp; Pirina, P . (2013). Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995&#x2013;2009. Journal of Neurology, 260(2), 572&#x2013;579. 10.1007/s00415-012-6681-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6681-5</ArticleId><ArticleId IdType="pubmed">23052600</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo, E. , Messina, P. , Logroscino, G. , Beghi, E. , &amp; SLALOM Group . (2014). Long&#x2010;term survival in amyotrophic lateral sclerosis: A population&#x2010;based study. Annals of Neurology, 75(2), 287&#x2013;297. 10.1002/ana.24096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24096</ArticleId><ArticleId IdType="pubmed">24382602</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond, J. , Oskarsson, B. , Mehta, P. , &amp; Horton, K . (2019). Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010&#x2013;2015. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(5&#x2013;6), 413&#x2013;420. 10.1080/21678421.2019.1612435</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1612435</ArticleId><ArticleId IdType="pmc">PMC6946020</ArticleId><ArticleId IdType="pubmed">31131638</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney, J. P. K. , Visser, A. E. , D'Ovidio, F. , Vermeulen, R. , Beghi, E. , Chio, A. , Veldink, J. H. , Logroscino, G. , van den Berg, L. H. , Hardiman, O. , &amp; Euro&#x2010;MOTOR Consortium . (2017). A case&#x2010;control study of hormonal exposures as etiologic factors for ALS in women: Euro&#x2010;MOTOR. Neurology, 89(12), 1283&#x2013;1290. 10.1212/WNL.0000000000004390</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004390</ArticleId><ArticleId IdType="pubmed">28835399</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman, K. J. , &amp; Greenland, S . (1998). Modern epidemiology (2nd ed.). Lippincott Williams and Wilkins.</Citation></Reference><Reference><Citation>Tiwari, R. C. , Clegg, L. X. , &amp; Zou, Z . (2006). Efficient interval estimation for age&#x2010;adjusted cancer rates. Statistical Methods in Medical Research, 15(6), 547&#x2013;569. 10.1177/0962280206070621</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280206070621</ArticleId><ArticleId IdType="pubmed">17260923</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, M. D. , Little, J. , Gomes, J. , Cashman, N. R. , &amp; Krewski, D . (2017). Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta&#x2010;analysis. Neurotoxicology, 61, 101&#x2013;130. 10.1016/j.neuro.2016.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.06.015</ArticleId><ArticleId IdType="pubmed">27377857</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, J. R. , Fitzhenry, D. , Grant, L. , Martyn, D. , &amp; Kerr, D. A . (2013). Diagnosis pathway for patients with amyotrophic lateral sclerosis: Retrospective analysis of the US Medicare longitudinal claims database. BMC Neurology, 13, 160. 10.1186/1471-2377-13-160</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-13-160</ArticleId><ArticleId IdType="pmc">PMC4029731</ArticleId><ArticleId IdType="pubmed">24499173</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>